Description

This injection combines ammonium glycyrrhetate, L-cysteine hydrochloride, and glycine in a balanced formula to support liver health by reducing inflammation, stabilizing cellular membranes, and enhancing detoxification. Commonly used in research related to acute and chronic hepatitis, drug-induced liver injury, and antioxidant studies. Administered via intravenous infusion after dilution.

Product Specifications

Mechanism of Action

• Ammonium glycyrrhetate stabilizes liver cell membranes, inhibits inflammatory mediators, and supports detox pathways.

• L-cysteine & glycine act as precursors for glutathione synthesis, reducing oxidative stress and aiding in liver regeneration .

Research Applications

• Acute, chronic, and toxic hepatitis models

• Oxidative damage and antioxidant response studies

• Inflammatory liver injury experiments

• Comparative research with other hepatoprotective agents

• Pharmacodynamics and pharmacokinetics in liver injury models

Safety & Handling

• Common lab-observed effects: mild nausea, allergic reaction, or fluid retention at high doses

• Administration: Dilute 20–80?ml in 250–500?ml of 5% glucose or saline for slow IV infusion once daily; IM or subcutaneous use also available per lab protocol

• Handling: Use lab PPE (gloves, coat, goggles), avoid aerosolizing agent

• Storage: Keep sealed, avoid freeze-thaw cycles

Core Keywords

compound ammonium glycyrrhetate injection, H13023812, ammonium glycyrrhetate L-cysteine glycine, hepatoprotective injection, lab-grade glycyrrhetate, liver injury research injection, wholesale liver protection injection

Research Use Disclaimer

This product is strictly for laboratory research use. It is not intended for medical diagnosis, therapeutic, clinical, or veterinary applications. Misuse may result in legal or health consequences. Follow institutional biosafety procedures.